Toreador Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Toreador Therapeutics, Inc., is leveraging groundbreaking, first-in-class DNA-based super resolution microscopy and proprietary TCE platforms uniquely suited for dual and triple targeting to make next generation drugs with unprecedented selectivity for oncology and autoimmune diseases. Our approach can be adapted to any antibody format or therapeutic modality and has novel drug opportunities for TCEs, bispecifics / multispecifics, ADCs, and radiopharmaceuticals.
NEXT GENERATION DRUGS TUNED TO BIOLOGY:
Target and drug biology that only we can track
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}